Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome
E. Klieser, Romana Urbas, Stefan Stättner, et al.
Human Pathology (2017) Vol. 65, pp. 41-52
Closed Access | Times Cited: 56

Showing 26-50 of 56 citing articles:

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
R. Schmitz, Julia Weißbach, Jan Kleilein, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1408-1408
Open Access | Times Cited: 17
Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
Judy S. Crabtree
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
Lei Yu, Huan Cao, Jianwang Yang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Acceleration in the DNA methylation age in breast cancer tumours from very young women
Sara S. Oltra, María Peña-Chilet, Kirsty Flower, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues
Wanyoung Lim, Inwoo Hwang, Jiande Zhang, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 6
A novel HDAC11 inhibitor potentiates the tumoricidal effects of cordycepin against malignant peripheral nerve sheath tumor through the Hippo signaling pathway.
Po-Yuan Huang, I-An Shih, Ying‐Chih Liao, et al.
PubMed (2022) Vol. 12, Iss. 2, pp. 873-892
Closed Access | Times Cited: 10
Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells
Maria J. Klomp, Simone U. Dalm, Peter M. van Koetsveld, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4905-4905
Open Access | Times Cited: 12
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer
Feng Chi, Jiayi Liu, Samuel W. Brady, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100946-100946
Open Access | Times Cited: 12
Translational challenges in pancreatic neuroendocrine tumor immunotherapy
Érika Said Abu Egal, Damian Jacenik, Heloisa P. Soares, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188640-188640
Open Access | Times Cited: 11
HDACs as an emerging target in endocrine tumors: a comprehensive review
E. Klieser, Bettina Neumayer, Pietro Di Fazio, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 143-154
Closed Access | Times Cited: 4
Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments
Susan Richter, Charlotte Steenblock, Alessa Fischer, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 17-32
Open Access | Times Cited: 4
Exploration of Mechanisms of Drug Resistance in a Microfluidic Device and Patient Tissues
Wanyoung Lim, Inwoo Hwang, Jiande Zhang, et al.
(2024)
Open Access | Times Cited: 1
Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study
Di Lu, Zhiqiang Ma, Di Huang, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 6, pp. 1119-1131
Open Access | Times Cited: 6
Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors
Maria J. Klomp, Julie Refardt, Peter M. van Koetsveld, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms
Rui Jiang, Xiafei Hong, Yupei Zhao, et al.
Cancer Letters (2020) Vol. 499, pp. 39-48
Closed Access | Times Cited: 8
High HDAC5 expression correlates with a poor prognosis and the tumor immune microenvironment in gastric cancer
Yuan Li, Can Hu, Pengcheng Yu, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 18, pp. 990-990
Open Access | Times Cited: 4
Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors
Chanjuan Shi, Michael A. Morse
Cancers (2022) Vol. 14, Iss. 24, pp. 6114-6114
Open Access | Times Cited: 4
Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns
Alexandra Posch, Sarah Hofer-Zeni, E. Klieser, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1625-1625
Open Access | Times Cited: 5
Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer
Jorseth Rodelo Gutiérrez, Arturo René Mendoza Salgado, Marcio De-Avila-Arias, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 9, pp. 1503-1542
Closed Access | Times Cited: 5
Epigenetic-based targeted therapies for well-differentiated pancreatic neuroendocrine tumors: recent advances and future perspectives
Francesca Marini, Francesca Giusti, Maria Luisa Brandi
Expert Review of Endocrinology & Metabolism (2021) Vol. 16, Iss. 6, pp. 295-307
Closed Access | Times Cited: 4
Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice
Maria J. Klomp, Lilian van den Brink, Peter M. van Koetsveld, et al.
Life Sciences (2023) Vol. 334, pp. 122173-122173
Open Access | Times Cited: 1
Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues
Wanyoung Lim, Inwoo Hwang, Jiande Zhang, et al.
eLife (2024) Vol. 12
Open Access
Epigenetics in precision medicine of pancreatic cancer
Hong Sun Kim, Jiaqi Shi
Elsevier eBooks (2021), pp. 257-279
Closed Access | Times Cited: 3
A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancer
Feng Chi, Jiayi Liu, Samuel W. Brady, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Biomarkers for prognosis in pancreatic neuroendocrine tumors
Mojun Zhu, K Sorenson, Rebecca Liu, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 12, pp. 773-782
Open Access | Times Cited: 1

Scroll to top